Abstract:Background: Circulating miRNAs (ci-miRNAs) are endogenous, non-coding RNAs emerging as potential diagnostic biomarkers. Equine miRNAs have been previously identified including subsets of tissue-specific miRNAs. In order to investigate ci-miRNAs as diagnostic tools, normal patterns of expression for different scenarios including responses to exercise need to be identified. Human studies have demonstrated that many ci-miRNAs are up-regulated following exercise with changes in expression patterns in skeletal muscle. However, technical challenges such as haemolysis impact on accurate plasma ci-miRNA quantification, with haemolysis often occurring naturally in horses following moderate-to-intense exercise. The objectives of this study were to identify plasma ci-miRNA profiles and skeletal muscle miRNAs before and after exercise in Thoroughbreds (Tb), and to evaluate for the presence and effect of haemolysis on plasma ci-miRNA determination. Resting and post-exercise plasma ci-miRNA profiles and haemolysis were evaluated in twenty 3 year-old Tbs in sprint training. Resting and post-exercise skeletal muscle miRNA abundance was evaluated in a second cohort of eleven 2 year-old Tbs just entering sprint training. Haemolysis was further quantified in resting blood samples from twelve Tbs in sprint training. A human plasma panel containing 179 miRNAs was used for profiling, with haemolysis assessed spectrophotometrically. Data was analysed using a paired Student's t-test and Pearson's rank correlation. Results: Plasma ci-miRNA data for 13/20 horses and all skeletal muscle miRNA data passed quality control. From plasma, 52/179 miRNAs were detected at both time-points. Haemolysis levels were greater than the threshold for accurate quantification of ci-miRNAs in 18/25 resting and all post-exercise plasma samples. Positive correlations (P < 0.05) between haemolysis and miRNA abundance were detected for all but 4 miRNAs, so exercise-induced changes in plasma ci-miRNA expression could not be quantified. In skeletal muscle samples, 97/179 miRNAs were detected with 5 miRNAs (miR-21-5p, let-7d-3p, let-7d-5p, miR-30b-5p, miR-30e-5p) differentially expressed (DE, P < 0.05) between time-points. Conclusions: The degree of haemolysis needs to be determined prior to quantifying plasma ci-miRNA expression from horses in high-intensity exercise training. Identification of DE miRNAs in skeletal muscle indicates modification of miRNA expression may contribute to adaptive training responses in Tbs. Using a human plasma panel likely limited detection of equine-specific miRNAs.

Plasma interleukin-6 concentration in Standardbred racehorses determined by means of a novel validated ELISA

An enhanced label-free proteomics approach for deep-diving into equine plasma proteome, including the discovery of protein biomarkers for strenuous exercise

Release kinetics of tumor necrosis factor-α and interleukin-1 receptor antagonist in the equine whole blood

Enhanced analysis of equine plasma for the presence of recombinant human erythropoietin - Implementation of an improved workflow

Development and validation of general plasma screening method for performance enhancing drugs in racehorses utilizing liquid chromatography-high-resolution mass spectrometry (LC-HRMS)

Development and use of an enzyme-linked immunosorbent assay to monitor serum and urine acepromazine concentrations in thoroghbreds, and possible changes associated with exercise

Evaluation of microRNA expression in plasma and skeletal muscle of thoroughbred racehorses in training

Discovery of Biomarkers of a Recombinant Human Erythropoietin Administration to Thoroughbred Geldings by Label-Free Proteomics

High levels of "complexed" interleukin-6 in human blood

Initial development of a rapid, portable, stall-side ELISA for the measurement of equine adrenocorticotropic hormone

Analytical and Clinical Validation of an Automated Microfluidic Interleukin-6 Immunoassay

The Detection and Measurement of Interleukin-6 in Venous and Capillary Blood Samples, and in Sweat Collected at Rest and During Exercise.

3-Methoxytyrosine as an indicator of dopaminergic manipulation in equine plasma

Enhanced Detection of Low Abundance Human Plasma Proteins Using a Tandem IgY12-SuperMix Immunoaffinity Separation Strategy

Comparison of three different methods for the quantification of equine insulin

A proteomics perspective on 2 years of high-intensity training in horses: a pilot study

High Amounts of Circulating Interleukin (IL)‐6 in the Form of Monomeric Immune Complexes During Anti‐il‐6 Therapy. Towards a New Methodology for Measuring Overall Cytokine Production in Human in Vivo

Selecting potential biomarkers of plasma proteins in mares with endometritis

Characterization of the plasma proteome from healthy adult dogs

Plasma Non-targeted Metabolomics Analysis of Yili Horses Raced on Tracks with Different Surface Hardness

Ultra-Sensitive and Semi-Quantitative Vertical Flow Assay for the Rapid Detection of Interleukin-6 in Inflammatory Diseases